In the pharmaceutical industry, Tenofovir Disoproxil Fumarate (TDF) 300 mg is a potent Nucleotide Reverse Transcriptase Inhibitor (NRTI). As a pharmacist and manufacturer, I classify this as a “backbone” therapy for viral management. It is a prodrug that effectively suppresses viral replication, making it a cornerstone of global health initiatives.
Primary Clinical Uses
HIV-1 Infection: It is a primary component of Highly Active Antiretroviral Therapy (HAART). It is always used in combination with at least two other antiretroviral medicines to treat adults and pediatric patients (weighing at least 35 kg).
Chronic Hepatitis B (HBV): It is a first-line monotherapy for the treatment of chronic hepatitis B in adults. It helps reduce the amount of HBV in the body and improves the condition of the liver.
PrEP (Pre-Exposure Prophylaxis): In combination with Emtricitabine, TDF is used by HIV-negative individuals at high risk of infection to prevent the acquisition of HIV.
Mechanism of Action: DNA Chain Termination
Tenofovir works by “tricking” the virus during its replication process.
Intracellular Activation: TDF is a prodrug. Once inside the cell, it is converted by cellular enzymes into its active form, Tenofovir Diphosphate.
Reverse Transcriptase Targeting: This active form competes with the natural substrate (deoxyadenosine 5′-triphosphate) for a spot in the viral DNA chain.
Chain Termination: Because Tenofovir lacks a necessary “hook” (the 3′-OH group) for the next building block to attach to, the viral DNA chain is broken. This prevents the virus from successfully replicating its genetic material.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your WHO-GMP facility in Mumbai, TDF 300 mg is a high-demand “Essential Medicine”:
The 300 mg Standard: This is the universal dose for HIV and HBV in adults. On your digital platforms, marketing this as a WHO-Prequalified equivalent is a major strategy for securing international NGO and government contracts.
Hygroscopic Nature: TDF is highly hygroscopic (absorbs moisture from the air). As a manufacturer, you know that specialized environmental controls (Low RH) are required during compression. We utilize Alu-Alu blister packaging or HDPE bottles with desiccant caps to ensure a 36-month shelf life in Zone IVb climates.
Renal Monitoring USP: As a pharmacist, your Product Information Leaflets (PIL) must emphasize monitoring of Creatinine Clearance and bone mineral density. This clinical accuracy on your website builds immense trust with B2B medical directors.
Dossier & Tenders: This molecule is the primary requirement for PEPFAR and Global Fund tenders. Our Mumbai facility provides full CTD/eCTD Dossiers to support your firm in registering this as a reliable generic against the innovator (Viread).